tradmap

HRTX Earnings HERON THERAPEUTICS, INC. /DE/

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $77M $155M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$227M -$114M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $20M $41M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$25M -$11M $4M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–21 of 21
Q2 20262026-06-30-0.072026-08-1010-Q
Q1 20262026-03-31-0.042026-05-1110-Q
FY 20252025-12-31-0.122026-02-2610-K
Q3 20252025-09-30-0.112025-11-0410-Q
Q2 20262025-06-300.002026-08-1010-Q
Q1 20262025-03-310.012026-05-1110-Q
FY 20252024-12-31-0.092026-02-2610-K
Q3 20252024-09-30-0.112025-11-0410-Q
Q2 20252024-06-30-0.082025-08-0810-Q
Q1 20252024-03-31-0.022025-05-0610-Q
FY 20252023-12-31-0.802026-02-2610-K
Q3 20242023-09-30-0.752024-11-1210-Q
Q2 20242023-06-30-0.632024-08-0610-Q
Q1 20242023-03-31-0.272024-05-0710-Q
FY 20242022-12-31-1.672025-02-2710-K
Q3 20232022-09-30-1.542023-11-1410-Q
Q2 20232022-06-30-1.182023-08-1410-Q
Q1 20232022-03-31-0.632023-05-1110-Q
FY 20222021-12-31-2.242023-03-2910-K
Q3 20222021-09-30-1.712022-11-0810-Q
Q2 20222021-06-30-1.202022-08-0910-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.